- Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RGS, Barzi A, Jemal A. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67(3):177-93. doi: 10.3322/caac.21395. PubMed PMID: 28248415.
- Kemp JA, Kwon YJ. Cancer nanotechnology: current status and perspectives. Nano Converg. 2021;8(1):34. doi: 10.1186/s40580-021-00282-7. PubMed PMID: 34727233. PubMed PMCID: PMC8560887.
- Karimi M, Karimian K, Heli H. A nanoemulsion-based delivery system for imatinib and in vitro anticancer efficacy. Braz J Pharm Sci. 2020;56:e18973. doi: 10.1590/s2175-97902020000118973.
- Negahdary M, Sattarahmady N, Heli H. Advances in prostate specific antigen biosensors-impact of nanotechnology. Clin Chim Acta. 2020;504:43-55. doi: 10.1016/j.cca.2020.01.028. PubMed PMID: 32004532.
- Dehdari Vais R, Heli H, Sattarahmady N. Label-free electrochemical DNA biosensing of MR TV 29 18s ribosomal RNA gene of Trichomonas vaginalis by signalization of non-spherical gold nanoparticles. J Mater Today Commun. 2023;34:105123. doi: 10.1016/j.mtcomm.2022.105123.
- Ilbeigi S, Ranjbar A, Zahraie N, Dehdari Vais R, Monjezi MR, Sattarahmady N. Sonodynamic therapy of pancreatic cancer cells based on synergistic chemotherapeutic effects of selenium-PEG-curcumin nanoparticles and gemcitabine. J Appl Phys A. 2023;129(2):82. doi: 10.1007/s00339-022-06377-0.
- Zahraie N, Haghighi H, Salehi F, Daneshvar F, Tamaddon P, Sattarahmady N. Pulsed sonodynamic therapy of melanoma cancer cells using nanoparticles of and mesoporous platinum. Ultrasound Med Biol. 2023;49(9):2160-8. doi: 10.1016/j.ultrasmedbio.2023.06.011. PubMed PMID: 37414634.
- Kayani Z, Islami N, Behzadpour N, Zahraie N, Imanlou S, Tamaddon P, et al. Combating cancer by utilizing noble metallic nanostructures in combination with laser photothermal and X-ray radiotherapy. J Drug Deliv Sci Technol. 2021;65:102689. doi: 10.1016/j.jddst.2021.102689
- Perota G, Faghani-Eskandarkolaei P, Zahraie N, Zare MH, Sattarahmady N. A Study of Sonodynamic Therapy of Melanoma C540 Cells in Vitro by Titania/Gold Nanoparticles. J Biomed Phys Eng. 2024;14(1):43-54. doi: 10.31661/jbpe.v0i0.2310-1674. PubMed PMID: 38357599. PubMed PMCID: PMC10862114.
- Sharma CP. Drug Delivery Nanosystems for Biomedical Applications. Elsevier; 2018.
- Heli H, Mirtorabi S, Karimian K. Advances in iron chelation: an update. Expert Opin Ther Pat. 2011;21(6):819-56. doi: 10.1517/13543776.2011.569493. PubMed PMID: 21449664.
- Negahdary M, Heli H. Applications of Nanoflowers in Biomedicine. Recent Pat Nanotechnol. 2018;12(1):22-33. doi: 10.2174/1872210511666170911153428. PubMed PMID: 28901846.
- Moghassemi S, Hadjizadeh A. Nano-niosomes as nanoscale drug delivery systems: an illustrated review. J Control Release. 2014;185:22-36. doi: 10.1016/j.jconrel.2014.04.015. PubMed PMID: 24747765.
- Bashkeran T, Kamaruddin AH, Ngo TX, Suda K, Umakoshi H, Watanabe N, Nadzir MM. Niosomes in cancer treatment: A focus on curcumin encapsulation. 2023;9(8):e18710. doi: 10.1016/j.heliyon.2023.e18710. PubMed PMID: 37593605. PubMed PMCID: PMC10428065.
- Ramaswamy B, Puhalla S. Docetaxel: a tubulin-stabilizing agent approved for the management of several solid tumors. Drugs Today (Barc). 2006;42(4):265-79. doi: 10.1358/dot.2006.42.4.968648. PubMed PMID: 16703123.
- Ganesh T. Improved biochemical strategies for targeted delivery of taxoids. Bioorg Med Chem. 2007;15(11):3597-623. doi: 10.1016/j.bmc.2007.03.041. PubMed PMID: 17419065. PubMed PMCID: PMC2374751.
- Lavelle F, Bissery MC, Combeau C, Riou JF, Vrignaud P, André S. Preclinical evaluation of docetaxel (Taxotere). Semin Oncol. 1995;22(2 Suppl 4):3-16. PubMed PMID: 7740328.
- Aapro M, Bruno R. Early clinical studies with docetaxel. Docetaxel Investigators Group. Eur J Cancer. 1995;31A(Suppl 4):S7-10. doi: 10.1016/0959-8049(95)00360-u. PubMed PMID: 7577102.
- Saloustros E, Georgoulias V. Docetaxel in the treatment of advanced non-small-cell lung cancer. Expert Rev Anticancer Ther. 2008;8(8):1207-22. doi: 10.1586/14737140.8.8.1207. PubMed PMID: 18699760.
- Kaye SB, Piccart M, Aapro M, Francis P, Kavanagh J. Phase II trials of docetaxel (Taxotere) in advanced ovarian cancer--an updated overview. Eur J Cancer. 1997;33(13):2167-70. doi: 10.1016/s0959-8049(97)00363-8. PubMed PMID: 9470802.
- Engels FK, Sparreboom A, Mathot RA, Verweij J. Potential for improvement of docetaxel-based chemotherapy: a pharmacological review. Br J Cancer. 2005;93(2):173-7. doi: 10.1038/sj.bjc.6602698. PubMed PMID: 16012521. PubMed PMCID: PMC2361544.
- Ren G, Liu D, Guo W, Wang M, Wu C, Guo M, et al. Docetaxel prodrug liposomes for tumor therapy: characterization, in vitro and in vivo evaluation. Drug Deliv. 2016;23(4):1272-81. doi: 10.3109/10717544.2016.1165312. PubMed PMID: 26965023.
- Syrigou E, Dannos I, Kotteas E, Makrilia N, Tourkantonis I, Dilana K, et al. Hypersensitivity reactions to docetaxel: retrospective evaluation and development of a desensitization protocol. Int Arch Allergy Immunol. 2011;156(3):320-4. doi: 10.1159/000324454. PubMed PMID: 21720178.
- Lee JJ, Swain SM. Peripheral neuropathy induced by microtubule-stabilizing agents. J Clin Oncol. 2006;24(10):1633-42. doi: 10.1200/JCO.2005.04.0543. PubMed PMID: 16575015.
- Ho MY, Mackey JR. Presentation and management of docetaxel-related adverse effects in patients with breast cancer. Cancer Manag Res. 2014;6:253-9. doi: 10.2147/CMAR.S40601. PubMed PMID: 24904223. PubMed PMCID: PMC4041377.
- Garrido-Siles M, Arenas-Villafranca JJ, Pérez-Ruiz E, De Linares Fernández MF, Tortajada B, Rivas-Ruiz F, et al. New cutaneous toxicities with generic docetaxel: are the excipients guilty? Support Care Cancer. 2015;23(7):1917-23. doi: 10.1007/s00520-014-2499-2. PubMed PMID: 25487841.
- Can G, Aydiner A, Cavdar I. Taxane-induced nail changes: Predictors and efficacy of the use of frozen gloves and socks in the prevention of nail toxicity. Eur J Oncol Nurs. 2012;16(3):270-5. doi: 10.1016/j.ejon.2011.06.007. PubMed PMID: 21784705.
- Mark M, Walter R, Meredith DO, Reinhart WH. Commercial taxane formulations induce stomatocytosis and increase blood viscosity. Br J Pharmacol. 2001;134(6):1207-14. doi: 10.1038/sj.bjp.0704387. PubMed PMID: 11704640. PubMed PMCID: PMC1573070.
- Pardakhty A, Moazeni E. Nano-niosomes in drug, vaccine and gene delivery: a rapid overview. Nanomed J. 2013;1(1):1-12. doi: 10.22038/NMJ.2013.697.
- Xin Y, Yin M, Zhao L, Meng F, Luo L. Recent progress on nanoparticle-based drug delivery systems for cancer therapy. Cancer Biol Med. 2017;14(3):228-41. doi: 10.20892/j.issn.2095-3941.2017.0052. PubMed PMID: 28884040. PubMed PMCID: PMC5570600.
- Jain S, Jain V, Mahajan SC. Lipid based vesicular drug delivery systems. Advances in Pharmaceutics. 2014:574673. doi: 10.1155/2014/574673.
- Sezgin-Bayindir Z, Yuksel N. Investigation of formulation variables and excipient interaction on the production of niosomes. AAPS PharmSciTech. 2012;13(3):826-35. doi: 10.1208/s12249-012-9805-4. PubMed PMID: 22644706. PubMed PMCID: PMC3429677.
- Kumar GP, Rajeshwarrao P. Nonionic surfactant vesicular systems for effective drug delivery—an overview. Acta Pharm Sin B. 2011;1(4):208-19. doi: 10.1016/j.apsb.2011.09.002.
- Ag Seleci D, Seleci M, Walter JG, Stahl F, Scheper T. Niosomes as nanoparticular drug carriers: fundamentals and recent applications. J Nanomater. 2016:7372306. doi: 10.1155/2016/7372306.
- Verma S, Singh SK, Syan N, Mathur P, Valecha V. Nanoparticle vesicular systems: a versatile tool for drug delivery. J Chem Pharm Res. 2010;2(2):496-509.
- Azeem A, Anwer MK, Talegaonkar S. Niosomes in sustained and targeted drug delivery: some recent advances. J Drug Target. 2009;17(9):671-89. doi: 10.3109/10611860903079454. PubMed PMID: 19845484.
- Kenicer J, Spears M, Lyttle N, Taylor KJ, Liao L, Cunningham CA, et al. Molecular characterisation of isogenic taxane resistant cell lines identify novel drivers of drug resistance. BMC Cancer. 2014;14:762. doi: 10.1186/1471-2407-14-762. PubMed PMID: 25312014. PubMed PMCID: PMC4203938.
- Majidi M, Safaee S, Amini M, Baghbanzadeh A, Hajiasgharzadeh K, Hashemzadeh S, et al. The effects of chemotherapeutic drugs on PD-L1 gene expression in breast cancer cell lines. Med Oncol. 2021;38(12):147. doi: 10.1007/s12032-021-01556-0. PubMed PMID: 34687372.
|